Advanced search
Publication Cover
Clinical Epidemiology Volume 12, 2020 - Issue
Submit an article Journal homepage
121
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Second Primary Cancers in Melanoma Patients Critically Shorten Survival

Guoqiao Zheng1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), HeidelbergD-69120, Germany;2 Faculty of Medicine, University of Heidelberg, Heidelberg, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4337-9017View further author information
ORCID Icon,
Subhayan Chattopadhyay1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), HeidelbergD-69120, Germany;2 Faculty of Medicine, University of Heidelberg, Heidelberg, GermanyORCID Iconhttps://orcid.org/0000-0002-8599-2971View further author information
ORCID Icon,
Kristina Sundquist3 Center for Primary Health Care Research, Lund University, Malmö205 02, Sweden;4 Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA;5 Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA;6 Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Shimane, JapanView further author information
,
Jan Sundquist3 Center for Primary Health Care Research, Lund University, Malmö205 02, Sweden;4 Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA;5 Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA;6 Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Shimane, JapanORCID Iconhttps://orcid.org/0000-0001-7228-5015View further author information
ORCID Icon,
Asta Försti1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), HeidelbergD-69120, Germany;3 Center for Primary Health Care Research, Lund University, Malmö205 02, SwedenORCID Iconhttps://orcid.org/0000-0002-9857-4728View further author information
ORCID Icon,
Akseli Hemminki7 Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland;8 Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, FinlandView further author information
&
Kari Hemminki1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), HeidelbergD-69120, Germany;3 Center for Primary Health Care Research, Lund University, Malmö205 02, Sweden;9 Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen30605, Czech RepublicView further author information
 show all
Pages 105-112 | Published online: 23 Jan 2020

References

  • Crocetti E, Mallone S, Robsahm TE, et al. Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study. Eur J Cancer. 2015;51(15):2179–2190. doi:10.1016/j.ejca.2015.07.03926421821
  • Lyth J, Eriksson H, Hansson J, et al. Trends in cutaneous malignant melanoma in Sweden 1997–2011: thinner tumours and improved survival among men. Br J Dermatol. 2015;172(3):700–706. doi:10.1111/bjd.2015.172.issue-325323770
  • Jemal A, Ward EM, Johnson CJ, et al. Annual report to the Nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst. 2017;109:9. doi:10.1093/jnci/djx030
  • Weyers W. Screening for malignant melanoma-a critical assessment in historical perspective. Dermatol Pract Concept. 2018;8(2):89–103. doi:10.5826/dpc.0802a0629785325
  • Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014;383(9919):816–827. doi:10.1016/S0140-6736(13)60802-824054424
  • Hartman RI, Lin JY. Cutaneous Melanoma-A review in detection, staging, and management. Hematol Oncol Clin North Am. 2019;33(1):25–38. doi:10.1016/j.hoc.2018.09.00530497675
  • Chattopadhyay S, Hemminki A, Försti A, Sundquist K, Sundquist J, Hemmiinki K. Familial risks and mortality in second primary cancers in melanoma. JNCI Cancer Spectr. 2019;2:pky068. doi:10.1093/jncics/pky06831360883
  • Read J, Wadt KA, Hayward NK. Melanoma genetics. J Med Genet. 2016;53(1):1–14. doi:10.1136/jmedgenet-2015-10315026337759
  • Talback M, Dickman PW. Predicting the survival of cancer patients recently diagnosed in Sweden and an evaluation of predictions published in 2004. Acta Oncol. 2012;51(1):17–27. doi:10.3109/0284186X.2011.62644422023089
  • De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15(1):23–34. doi:10.1016/S1470-2045(13)70546-124314615
  • Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1(11):710–719. doi:10.1200/JCO.1983.1.11.7106668489
  • Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer. 1996;73:255–259. doi:10.1038/bjc.1996.458546916
  • Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5 Suppl 1):S78–S86. doi:10.1016/j.jaad.2011.05.03022018071
  • Utjes D, Lyth J, Lapins J, Eriksson H. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study. Int J Cancer. 2017;141(11):2243–2252. doi:10.1002/ijc.v141.1128799271
  • Enninga EAL, Moser JC, Weaver AL, et al. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992–2011. Cancer Med. 2017;6(10):2203–2212. doi:10.1002/cam4.115228879661
  • Robsahm TE, Helsing P, Nilssen Y, et al. High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. Clin Epidemiol. 2018;10:537–548. doi:10.2147/CLEP.S15124629780262
  • Youlden DR, Baade PD, Soyer HP, et al. Ten-year survival after multiple invasive melanomas is worse than after a single melanoma: a population-based study. J Investig Dermatol. 2016;136(11):2270–2276. doi:10.1016/j.jid.2016.03.01427019458
  • Pardo L, van der Leest R, De Vries E, Soerjomataram I, Nijsten T, Hollestein L. Comparing survival of patients with single or multiple primary melanoma in the Netherlands: 1994–2009. Br J Dermatol. 2017;176(2):531–533. doi:10.1111/bjd.2017.176.issue-227377396
  • Zheng G, Chattopadhyay S, Sud A, et al. Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients. Blood Cancer J. 2019;9(4):40. doi:10.1038/s41408-019-0201-030914634
  • Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 2013;10(5):289–301. doi:10.1038/nrclinonc.2013.4123529000
  • Chen T, Fallah M, Forsti A, Kharazmi E, Sundquist K, Hemminki K. Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas. JAMA Dermatol. 2015;151(6):607–615. doi:10.1001/jamadermatol.2014.477725671687
  • Chen T, Hemminki K, Kharazmi E, Ji J, Sundquist K, Fallah M. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. Eur J Cancer. 2014;50(15):2659–2667. doi:10.1016/j.ejca.2014.07.00725103454
  • Frödin J-E, Ericsson J, Barlow L. Multiple primary malignant tumors in a national cancer registry. Reliability of reporting. Acta Oncol. 1997;36:465–469. doi:10.3109/028418697090013009292741

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.